Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Coordination of intratumoral immune reaction and human colorectal cancer recurrence.

Camus M, Tosolini M, Mlecnik B, Pagès F, Kirilovsky A, Berger A, Costes A, Bindea G, Charoentong P, Bruneval P, Trajanoski Z, Fridman WH, Galon J.

Cancer Res. 2009 Mar 15;69(6):2685-93. doi: 10.1158/0008-5472.CAN-08-2654. Epub 2009 Mar 3.

2.

Effector memory T cells, early metastasis, and survival in colorectal cancer.

Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J.

N Engl J Med. 2005 Dec 22;353(25):2654-66.

3.

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH, Galon J.

J Clin Oncol. 2009 Dec 10;27(35):5944-51. doi: 10.1200/JCO.2008.19.6147. Epub 2009 Oct 26.

4.

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F.

Science. 2006 Sep 29;313(5795):1960-4.

5.

[Effect of tumor burden on differentiation of T lymphocytes in the peripheral blood of patients with colorectal cancer].

Cui M, Wang S, Ye YJ, Cui ZR, Ke Y.

Zhonghua Yi Xue Za Zhi. 2007 Jan 2;87(1):16-9. Chinese.

PMID:
17403305
6.

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.

Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S.

Clin Cancer Res. 2006 May 1;12(9):2795-803.

7.

Phenotyping of immune cell infiltrates in breast and colorectal tumours.

Toomey D, Harmey J, Condron C, Kay E, Bouchier-Hayes D.

Immunol Invest. 1999 Jan;28(1):29-41.

PMID:
10073680
8.

The essential role of the in situ immune reaction in human colorectal cancer.

Pagès F, Galon J, Fridman WH.

J Leukoc Biol. 2008 Oct;84(4):981-7. doi: 10.1189/jlb.1107773. Epub 2008 Jun 17.

9.

Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma.

Saito S, Tsuno N, Nagawa H, Sunami E, Zhengxi J, Osada T, Kitayama J, Shibata Y, Tsuruo T, Muto T.

Cancer. 2000 Jan 1;88(1):42-9.

PMID:
10618604
10.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
11.

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Göbel G, Margreiter R, Königsrainer A, Fuchs D, Amberger A.

Clin Cancer Res. 2006 Feb 15;12(4):1144-51.

12.

Memory T-cell responses and survival in human cancer: remember to stay alive.

Camus M, Galon J.

Adv Exp Med Biol. 2010;684:166-77. Review.

PMID:
20795548
13.

Endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis.

Jayasinghe C, Simiantonaki N, Michel-Schmidt R, Kirkpatrick CJ.

Oncol Rep. 2009 Nov;22(5):1093-100.

PMID:
19787226
15.
16.

Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.

Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pagès F, Galon J.

Cancer Res. 2011 Feb 15;71(4):1263-71. doi: 10.1158/0008-5472.CAN-10-2907. Epub 2011 Feb 8. Erratum in: Cancer Res. 2011 Jul 1;71(13):4732.

17.

Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape.

Huber V, Fais S, Iero M, Lugini L, Canese P, Squarcina P, Zaccheddu A, Colone M, Arancia G, Gentile M, Seregni E, Valenti R, Ballabio G, Belli F, Leo E, Parmiani G, Rivoltini L.

Gastroenterology. 2005 Jun;128(7):1796-804.

PMID:
15940614
18.

Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.

Soumaoro LT, Uetake H, Takagi Y, Iida S, Higuchi T, Yasuno M, Enomoto M, Sugihara K.

Dis Colon Rectum. 2006 Mar;49(3):392-8.

PMID:
16474989
19.

Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.

Maccalli C, Di Cristanziano V, Fodale V, Corsi D, D'Agostino G, Petrangeli V, Laurenti L, Guida S, Mazzocchi A, Arienti F, Perrone MP, Castelli C, Rivoltini L, Zagonel V, Tartaglia M, Parmiani G, Belardelli F.

Clin Cancer Res. 2008 Nov 15;14(22):7292-303. doi: 10.1158/1078-0432.CCR-08-0832. Epub 2008 Oct 30.

20.

Perioperative IFN-alpha to avoid surgically induced immune suppression in colorectal cancer patients.

Oosterling SJ, van der Bij GJ, Mels AK, Beelen RH, Meijer S, van Egmond M, van Leeuwen PA.

Histol Histopathol. 2006 Jul;21(7):753-60. Review.

PMID:
16598674
Items per page

Supplemental Content

Write to the Help Desk